SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Roivant Sciences Ltd.
@ROIV_InsiderForm 4 Filing: Venker Eric Sells $7.8M of $ROIV
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Roivant Sciences Ltd.
Ticker: $ROIV
Transaction Value
$7.8M
Price/Share: $19.40
transaction date
2026-07-27
Shares: 400,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Venker Eric, holds the title of President & Immunovant CEO at Roivant Sciences Ltd..
On 2026-07-27, the insider transacted 400,000 shares.The shares were transacted at a weighted average price of $19.40 per share, resulting in a total market-relevant value of $7.8M.
Executive Summary Summary
Venker Eric (President & Immunovant CEO) sold $7.8M of $ROIV
Post-Transaction Position: 1,613,063 shares
SEC Accession No: 0001140361-26-030107 (CIK: 1801917)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.